Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Pretorius E, Venter C, Laubscher GJ, Kotze MJ, Oladejo SO, Watson LR, et al
Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes Huang Y, He Y, Makarcyzk MJ, Lin H Frontiers in Bioengineering and Biotechnology (2021) This study demonstrated that FOXO4-DRI selectively removes senescent cells from human chondrocyte cultures expanded in vitro, providing direct evidence of the peptide's senolytic activity in human cells relevant to joint and cartilage aging
The health and safety hazards associated with the handling of peptides in a research setting
Irregularity in menstrual cycle Vitamin B12 deficiency can contribute to hormonal imbalances in women, affecting the production of estrogen, progesterone, and even testosterone
Retatrutide (Triple GLP-1/GIP/Glucagon Agonist) Research Peptide $ 189.00 $ 479.00Price range: $ 189.00 through $ 479.00 Retatrutide (GLP1 R) is a 39-amino-acid triple receptor agonist research peptide that activates GLP-1, GIP, and glucagon receptors simultaneously, studied for its role in multi-pathway incretin signaling and metabolic receptor interaction research
